NCT06949722 Redirecting Poor Sleep Drivers of Early Cardiovascular Disease
| NCT ID | NCT06949722 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National University of Singapore |
| Condition | Sleep |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2025-03-24 |
| Primary Completion | 2027-08-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2025-03-24 with a primary completion date of 2027-08-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sleep health is a critical component of cardiovascular well-being, and poor sleep has been linked with increased risk for all-cause mortality including cardiovascular disease (CVD). Moreover, many individuals within a population may have underlying, subclinical cardiovascular conditions, such as hypertension and arterial stiffness, and these may risk progressing to advanced CVD when coupled with inadequate sleep duration and quality. Given that Singapore ranks as the third most sleep-deprived city globally, understanding the relationship between sleep health and the prevalence and progression of CVD becomes increasingly important for population health. In addition, depression and psychological stress could also lead to poorer cardiovascular health by increasing blood cholesterol, blood sugar and blood pressure, and could also be directly related to or arise as a result of poor sleep. The aim of the current study is to track sleep and mental health using a combination of objective sleep tracking (Oura ring) and smartphone-based questionnaires (EMA), and examine their associations with detailed cardiovascular health data collected by the project RESET (Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease).
Eligibility Criteria
Inclusion Criteria: * Willing to wear a ring * Have any of the following conditions: * High blood pressure * High cholesterol * Fatty liver * Family history of heart diseases or stroke. * Obesity Exclusion Criteria: * Prior history of heart attack or stroke or balloon angioplasty/stent placement * Restricted peripheral circulation (e.g., Raynaud's disease) * Pacemakers
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06949722 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 70 Years, studying Sleep. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06949722 currently recruiting?
Yes, NCT06949722 is actively recruiting participants. Contact the research team at julynn.ong@nus.edu.sg for enrollment information.
Where is the NCT06949722 trial being conducted?
This trial is being conducted at Singapore, Singapore.
Who is sponsoring the NCT06949722 clinical trial?
NCT06949722 is sponsored by National University of Singapore. The trial plans to enroll 1,500 participants.